March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Initial Experience Using A Collagen Matrix Implant (OlogenTm) As A Wound Modulator With Canaloplasty: 12 Month Results
Author Affiliations & Notes
  • Matthew S. Johnson
    Ophthalmology, Dean McGee Eye Institute, Oklahoma City, Oklahoma
  • Steven Sarkisian
    Ophthalmology, Dean McGee Eye Institute, Oklahoma City, Oklahoma
  • Nathan Blessing
    Ophthalmology, Oklahoma University Health Science Center, Oklahoma City, Oklahoma
  • James M. Rouse
    Ophthalmology, Dean McGee Eye Institute, Oklahoma City, Oklahoma
  • Footnotes
    Commercial Relationships  Matthew S. Johnson, None; Steven Sarkisian, iScience (C), Optous (C); Nathan Blessing, None; James M. Rouse, None
  • Footnotes
    Support  This research was supported in part by Research to Prevent Blindness
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 2508. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Matthew S. Johnson, Steven Sarkisian, Nathan Blessing, James M. Rouse; Initial Experience Using A Collagen Matrix Implant (OlogenTm) As A Wound Modulator With Canaloplasty: 12 Month Results. Invest. Ophthalmol. Vis. Sci. 2012;53(14):2508.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To investigate the success rate of a collagen matrix implant as a wound modulator in canaloplasty.

Methods: : A retrospective review was performed of 22 consecutive eyes with 12 months of follow up data after undergoing canaloplasty using collagen in the scleral lake. Main outcome measures included post-operative IOP, number of anti-glaucoma medications, and post-operative complications. Complete surgical success was defined as an IOP ≤ 21, 18, and 16 mm Hg without medications, and qualified success with or without medications.

Results: : The mean IOP dropped from 23.0 ± 7.0 mm Hg preoperatively to 13.4 ± 3.3 mm Hg at 12 months. Mean number of medications dropped from 1.8 ± 1.0 preoperatively to 0.59 ± 0.85 at 12 months. Complete surgical success was achieved in 54.5% of patients, all of whom had an IOP ≤ 16 mm Hg. The qualified success rate of an IOP ≤ 21, 18, and 16 mm Hg was 100%, 95.5%, and 72.7%, respectively. Post-operative complications included transient conjunctival leaks in 6 eyes, shallow anterior chamber in 1 eye, and bleb formation in 1 eye. Post-operative interventions included laser goniopuncture performed in 5 eyes, iridoplasty performed in 1 eye, and bleb revision performed in 1 eye. Mean IOP before goniopuncture was 32.4 ± 19.3 mmHg, and was 17.6 ± 7.9 mm Hg on the subsequent post-procedure visit.

Conclusions: : Surgical success indicates a collagen matrix implant may be a useful adjunct in canaloplasty.

Keywords: outflow: trabecular meshwork • wound healing 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×